Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
医学
切碎
内科学
淋巴瘤
肿瘤科
作者
Adrian Minson,Emma Verner,Pratyush Giri,Jason M. Butler,Wojciech Janowski,Chan Y. Cheah,Sumita Ratnasingam,Shu Min Wong,Matthew Ku,Mark P. Hertzberg,Kirsten Herbert,Nada Hamad,Costas K. Yannakou,Fiona Swain,Paul J. Neeson,Thiago M. Steiner,Javad Saghebi,Piers Blombery,Sally M. Hunter,Molly Robertson
The combination of glofitamab with R-CHOP or Pola-R-CHP is deliverable and results in high rates of durable response in this population of younger patients with high-burden, HR LBCL, supporting its ongoing exploration as a 1L treatment.